TNF and type 2 diabetes mellitus: NON-RATT021972 siRNA treatment suppressed the up-regulated expression and activation of the P2 × 3 receptor and reduced the hyperalgesia potentiated by the pro-inflammatory cytokine TNF-α in Type 2 diabetes mellitus rats.